ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619031 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619031; 2) Community: the network communities that were significantly associated with the response to NSC 619031; 3) Molecule: the relationships between components within communities and NSC 619031; 4) MDR: the compounds that were significantly associated with the NSC 619031.

NSC Compound Enrichment Correlation
NSC 687523 Null 0.00142226725147591 0.10907621
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.00142226725147591 0.75691248
NSC 632737 Tris(1,10-phenanthroline)lanthanum(III)-trithiocyanate 0.0019693378177718 0.15832919
NSC 641461 Null 0.0019693378177718 0.61512523
NSC 670163 Null 0.0019693378177718 0.16071069
NSC 681644 Camptothecin Derivative 0.00227699677919299 0.82067281
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.00227699677919299 0.64656077
NSC 734406 Null 0.00227699677919299 0.19384214
NSC 95382 Camptothecin Derivative 0.00227699677919299 0.71047364
NSC 295501 Camptothecin Derivative 0.00228818143845077 0.70953953
Total:40  Current:4    [First] [Prev] [Next] [Last]